When Parkinson's medicines stop covering the day
When Parkinson's treatment no longer covers the day, the next step is to identify what has changed. Wearing-off, troublesome involuntary movements and symptoms that respond poorly to levodopa lead to different treatment discussions.
On this page
Describe the problem in ordinary daily terms
Perhaps getting dressed is difficult before the first dose, walking slows before the next tablet, or involuntary movements interrupt meals. These examples help a specialist understand fluctuations better than a general statement that medication has stopped working.
Keep a brief diary of doses, meals, movement and the difficult periods. Record good periods too: they show what function is still possible when treatment is working. Bring every medicine and supplement to the review, with exact strengths and times. Ask the clinician how many days of observation would be most useful.
Sources and references: [1]
Review medicines before assuming surgery is next
A movement-disorders review can consider the timing and formulation of levodopa and whether an additional drug is appropriate. Dopamine agonists, MAO-B inhibitors and COMT inhibitors have different roles and adverse effects.
More treatment is not automatically better treatment. Daytime sleepiness, hallucinations, dizziness and changes in impulse control can limit a regimen. Tell the clinician about these even if walking has improved. A family member's observations may help, especially when a behavioural change is easier for others to recognize.
Sources and references: [1]
Check which symptoms improve with levodopa
The response during a good medication period helps frame expectations for advanced treatment. DBS assessment often compares movement before and after a supervised dose. Tremor can sometimes be considered differently from other motor symptoms.
Persistent falls, major thinking changes or symptoms that fit poorly with the current diagnosis deserve a fresh neurological review. Ask which difficulty is likely to improve with the proposed treatment and which needs a separate approach. Do not withhold medication to create an off period unless the assessing team has given you specific instructions.
Sources and references: [2]
When infusion therapies may be discussed
For selected people with difficult fluctuations, a specialist may consider treatment delivered by injection or a pump. The options differ in how the drug enters the body and what equipment and daily care are required.
Ask what benefit the team expects compared with the best tablet regimen, who will manage the equipment and what to do if delivery is interrupted. Availability, product authorization and support arrangements vary between countries. A treatment used in a foreign guideline should be checked against the actual service proposed for your care in Shanghai.
Sources and references: [1]
What DBS adds to the discussion
DBS uses implanted leads and a pulse generator to influence selected brain circuits. It can help suitable patients manage certain movement symptoms and fluctuations. Assessment includes the neurological pattern, response to medication, cognition, mood and the ability to attend follow-up.
The operation also brings risks such as bleeding and infection, as well as the need for programming and device care. Ask the team to compare DBS with continued medicine adjustment and any suitable infusion option using your own priorities. The useful outcome might be more predictable time for meals or walking, rather than the disappearance of every symptom.
Keep rehabilitation and non-motor care in the plan
Physiotherapy and occupational therapy address walking, flexibility and daily activities. Speech and swallowing support may also be needed. Sleep, constipation, mood and blood-pressure symptoms can remain important even when movement treatment is improved.
Prepare a list of the problems that most affect independence. If a companion is already providing considerable help, explain what the daily routine involves. The treatment plan should identify who will address each problem and when it will be reviewed, so a technically successful motor treatment does not leave the most difficult parts of the day unattended.
Sources and references: [1]
Ask for a Shanghai movement-disorders review
Huashan Hospital is a relevant Shanghai resource for neurology and neurosurgery assessment. EastMedGo can help prepare a focused enquiry about poor symptom control and the next treatment options.
Send your diagnosis history, drug schedule, previous treatment changes and a short record of good and difficult periods. Include prior MRI reports and any cognitive or psychological assessments. We can help clarify which specialist should review the records, whether additional assessments are needed and how follow-up would work if treatment continues across two countries.
Sources and references: [4]
Common questions
Does wearing-off mean levodopa is no longer useful?
It can mean that benefit does not last until the next dose. The specialist reviews the pattern and possible regimen changes rather than assuming the drug has lost all value.
Sources and references: [1]
Is DBS appropriate for every person with advanced Parkinson's?
Suitability depends on the symptom pattern, medication response, cognition, mood and overall health. Advanced symptoms alone do not establish that surgery is the best next step.
Should I stop medicines before a second opinion?
Continue the agreed regimen unless the assessing team gives specific instructions for a supervised examination. Bring the timing and doses so the specialist can interpret your symptoms.
Sources and references: [2]
Sources and references
- NHS: Parkinson's disease treatment
- Oxford University Hospitals: DBS pre-operative information
- Mayo Clinic: Deep brain stimulation
- Huashan Hospital Affiliated to Fudan University
Prepared with AI assistance by EastMedGo for patients comparing treatment and care options.